Europe Healthcare 3D Printing Market to surpass $ 650 Mn by 2024

March 05, 2020


The research report titled ‘Europe Healthcare 3D Printing Market Size by Product, Application, Technology, Industry Analysis Report, Country Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2024’, which is available at MarketStudyReport.com, provides an extensive assessment of the industry dynamics and the growth factors of Europe healthcare 3D printing market.
 

According to the report, Europe healthcare 3D printing industry is expected to cross USD 650 million by the year 2024. Increasing application of 3D printing in burns & injuries, bioprinting, and tissue engineering is a major factor driving the market growth. 3D printing technology is used to produce layers of human skin for patients with critical injuries, accidental wounds, or severe burns. This factor along with increased pervasiveness of trauma incidents and accidents are further aiding the expansion of the market.
 

Also, numerous market majors are focusing on developing innovative 3D printing solutions, for instance, software which enables scanning through smartphones. This factor in tandem with the inclination of biotech companies towards producing organs and tissues using 3D printer is propelling the market share. However, high cost of 3D printing software may hinder the overall market growth in the ensuing years.  
 

As per product type, the report states that syringe based 3D printing market segment was worth USD 70 million in the year 2017 and is expected to register significant growth during the study period. Syringe based 3D printer offers better control over the flowrate of material and superior flexibility. Adding to this, various materials used in these printers are frostings, conductive polymers, cells, and silicone. Thus, rising adoption of syringe-based 3D printers in healthcare for developing advanced structures is fueling the segmental growth.
 

In terms of technology, FDM (fused deposition modeling) segment held 40% market share in the year 2017 and is presumed to expand continuously during the forecast period. This technology is cost-effective in nature as compared to its counterparts. This factor along with rising adoption of FDM technology for developing scaffolds for medical tissue engineering in healthcare sector is facilitating the business scenario.
 

Based on the application spectrum, biosensors application of healthcare 3D printing in Europe is predicted to cross USD 125 million by the year 2024. Growing demand for biosensors in R&D and shifting focus towards development of novel sensor systems in order to monitor patient conditions are boosting the growth of the segment.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2506064/
 

As per regional analysis, the report cites that Germany healthcare 3D printing industry amassed USD 30 million in the year 2018 and will witness constant growth during the estimated timeframe.  Advancements in 3D printing technology along with rising adoption of the product across medical applications is driving the market growth in Germany. Growing demand for patient specific prosthesis and increasing R&D investments are favoring the market outlook.
 

TeVido BioDevices, Stratasys, Solidscape, Renishaw, regenHU Ltd., Organovo Holdings, Inc., Oceanz, Materialise, Luxexcel, Envision TEC, Digilab, BioBots, Bio 3D Technologies, Aspect Biosystems, 3Dynamics Systems, 3D Systems, 3D Bioprinting Solutions, and 3D Biotek are the prominent companies operating in Europe healthcare 3D printing market.


Frequently Asked Questions (FAQ) :

Increasing application of 3D printing in burns & injuries, bioprinting and tissue engineering is a major factor driving the growth of Europe 3D printing market. 3D printing technology is used to produce layers of human skin for patients with critical injuries, accidental wounds, or severe burns. This factor along with increased pervasiveness of trauma incidents and accidents are further aiding the expansion of the market. Also, numerous market majors focusing on developing innovative 3D printing solutions, for instance, software which enables scanning through smartphones. This factor in tandem with the inclination of biotech companies towards producing organs and tissues using 3D printer is propelling the market share.
The report states that syringe based 3D printing market segment was worth USD 70 million in the year 2017 and is expected to register significant growth during the study period. Syringe based 3D printer offers better control over the flowrate of material and superior flexibility. Adding to this, various materials used in these printers are frostings, conductive polymers, cells, and silicone. Thus, rising adoption of syringe-based 3D printers in healthcare for developing advanced structures is fueling the segmental growth.
The report cites that Germany healthcare 3D printing market amassed USD 30 million in the year 2018 and will witness constant growth during the estimated timeframe. Advancements in 3D printing technology along with rising adoption of the product across medical applications is driving the market growth in Germany. Growing demand for patient specific prosthesis and increasing R&D investments are favoring the market outlook.
TeVido BioDevices, Stratasys, Solidscape, Renishaw, regenHU Ltd., Organovo Holdings, Inc., Oceanz, Materialise, Luxexcel, Envision TEC, Digilab, BioBots, Bio 3D Technologies, Aspect Biosystems, 3Dynamics Systems, 3D Systems, 3D Bioprinting Solutions, and 3D Biotek are the prominent companies operating in Europe healthcare 3D printing market.